연구성과로 돌아가기

2024 연구성과별 연구자 정보 (1558 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study Hwang, S. W. Hwang, SW 15 Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Internal Med, Seoul, South Korea
One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study Hwang, S. W. Hwang, SW 15 Univ Ulsan, Coll Med, Asan Med Ctr, Inflammatory Bowel Dis Ctr, Seoul, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Lee, C. K. Lee, CK 1 Kyung Hee Univ Hosp, Kyung Hee Univ Coll Med, Ctr Crohns & Colitis, Gastroenterol, Seoul, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Moon, W. Moon, W 2 Kosin Univ Coll Med, Internal Med, Busan, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Chun, J. Chun, J 3 Yonsei Univ Coll Med, Gangnam Severance Hosp, Internal Med, Seoul, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Kim, E. S. Kim, ES 4 Kyungpook Natl Univ, Sch Med, Internal Med, Daegu, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Kim, H. W. Kim, HW 5 Pusan Natl Univ Yangsan Hosp, Internal Med, Busan, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Yoon, H. Yoon, H 6 Seoul Natl Univ Bundang Hosp, Internal Med, Seongnam, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Kim, H. S. Kim, HS 7 Chonnam Univ Med Sch, Internal Med, Gwangju, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Lee, Y. J. Lee, YJ 8 Keimyung Univ Sch Med, Internal Med, Daegu, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Choi, C. H. Choi, CH 9 Chung Ang Univ, Internal Med, Coll Med, Seoul, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Jung, Y. Jung, Y 10 Soonchunhyang Univ Coll Med, Internal Med, Cheonan, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Park, S. C. Park, SC 11 Kangwon Natl Univ, Sch Med, Gastroenterol & Hepatol Internal Med, Chunchon, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Song, G. A. Song, GA 12 Pusan Natl Univ Coll Med, Internal Med, Busan, South Korea
One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study Lee, J. H. Lee, JH 13 Dong A Univ Med Ctr, Internal Med, Busan, South Korea
페이지 이동: